INTERNATIONAL PATENT: SHUTTLE PHARMACEUTICALS HOLDINGS, INC. FILES APPLICATION FOR "BORON CONTAINING PSMA LIGAND FOR USE IN THE TREATMENT OF CANCER"

GENEVA, Sept. 10 -- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. (401 Professional Drive, Suite 260Gaithersburg, Maryland 20879) filed a patent application (PCT/US2025/017827) for "BORON CONTAINING PSMA LIGAND FOR USE IN THE TREATMENT OF CANCER" on Feb 28, 2025. With publication no. WO/2025/184495, the details related to the patent application was published on Sep 04, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KOZIKOWSKI, Alan (C/O Shuttle Pharmaceuticals Holdings, Inc.401 Professional Drive, Suite 260Gaithersburg, Maryland 20879), TUECKMANTEL, Werner (C/O Shuttle Pharmaceuticals Holdings, In...